Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Verastem, Inc. (VSTM)

Verastem Q3 preliminary product revenue $23.9 million to $24.1 million; CEO to retire

Positive Impact 4 of 5 earnings Written later

Verastem reported preliminary unaudited third-quarter 2026 net product revenue of $23.9 million to $24.1 million, up from $11.2 million a year earlier, and estimated cash, cash equivalents and investments of $172.8 million at September 30, 2026. The company also said CEO Daniel Paterson will retire effective January 1, 2027, and Michael Bailey will succeed him. The financial figures are unaudited and subject to change during closing procedures.

Key points

  • Preliminary Q3 2026 net product revenue: $23.9 million to $24.1 million, compared with $11.2 million for Q3 2025.
  • Estimated cash, cash equivalents and investments at September 30, 2026: $172.8 million, compared with $137.7 million a year earlier.
  • Daniel Paterson to retire as President and CEO effective January 1, 2027, and remain on the Board and as a consultant or advisor.
  • Michael Bailey, 61, to become President and CEO effective January 1, 2027; he previously served as CEO of AVEO Pharmaceuticals.

The filing

CompanyVerastem, Inc. (VSTM)
Form8-K, current report
Filed with the SECOct 14, 2026, 6:08 AM ET
Accession number0001104659-26-115687

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.